Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Active & Responsive
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Get alerts for new trials in your area by subscribing now
Active & Responsive
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
for
Interstitial Lung Disease
Location: Durham NC
Sponsor: Bastiaan Driehuys
Sex: All
Age: 18+
Code: NCT01280994
Phase 2, Recruiting
Active & Responsive
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
for
X-linked Retinoschisis
Location: Durham NC, Philadelphia PA, New York NY, Ann Arbor MI,
Sponsor: Atsena Therapeutics Inc.
Sex: All
Age: 5+
Code: NCT05878860
Phase 3, Recruiting
Active & Responsive
Asciminib in HER2+ Breast Cancer Brain Metastases
for
HER2+ Metastatic Breast Cancer
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT07136428
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Durham NC, Pittsburgh PA, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & Responsive
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
for
Periprosthetic Joint Infection
Location: Durham NC, Charlotte NC, Lansing MI
Sponsor: OsteoRemedies, LLC
Sex: All
Age: 21+
Code: NCT06428448
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Durham NC, Charlotte NC, Chesapeake VA, Rockville MD,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
for
Pompe Disease
Location: Durham NC, Fairfax VA, Atlanta GA, Pittsburgh PA,
Sponsor: Shionogi
Sex: All
Age: 18+
Code: NCT07123155
Phase 2, Recruiting
Active & Responsive
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma